CSIMarket Company Name, Ticker, Competitors, else..
 
Janux Therapeutics Inc   (NASDAQ: JANX)
 

Janux Therapeutics Inc's Suppliers Performance

JANX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
JANX Costs vs Sales of Suppliers Growth

• More on JANX Suppliers






Janux Therapeutics Inc's Comment on Supply Chain


The company manufactures TRACTrs, TRACIrs, and ARMs using raw materials and starting components sourced from multiple qualified third-party manufacturers compliant with cGMP requirements. Each product platform has a master cell bank produced and tested according to cGMP standards, stored in two independent locations, with plans to develop working cell banks in later stages. Bulk drug substance (BDS) is obtained from a third-party contract manufacturer under agreements that secure required quantities for development and commercial purposes. The company maintains backup cell banks and sufficient BDS and manufacturing capacity to support clinical trials.

Janux Therapeutics Inc's Comment on Supply Chain


The company manufactures TRACTrs, TRACIrs, and ARMs using raw materials and starting components sourced from multiple qualified third-party manufacturers compliant with cGMP requirements. Each product platform has a master cell bank produced and tested according to cGMP standards, stored in two independent locations, with plans to develop working cell banks in later stages. Bulk drug substance (BDS) is obtained from a third-party contract manufacturer under agreements that secure required quantities for development and commercial purposes. The company maintains backup cell banks and sufficient BDS and manufacturing capacity to support clinical trials.







JANX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Janux Therapeutics Inc 1,049.79 13.05 -102.59 109
SUBTOTAL 0.00 0.00 0.00 -


Sources: Janux Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Janux Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.